CAAS Capital Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-22,000
Closed -$500K 867
2022
Q4
$500K Buy
+22,000
New +$612K 0.03% 454
2021
Q3
Sell
-125,000
Closed -$5.55M 1082
2021
Q2
$5.55M Buy
+125,000
New +$4.61M 0.09% 221

Other funds holding PRVA

CAAS Capital Management's PRVA Position: Q1 2023 in Review

CAAS Capital Management sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 22,000 shares — an estimated $500K sold.

CAAS Capital Management first reported a position in PRVA in Q2 2021 and held it in 2 quarters. The position peaked at $5.55M in Q2 2021. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

  • CAAS Capital Management reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
  • CAAS Capital Management sold 22,000 Privia Health shares in Q1 2023, an estimated $500K.
  • CAAS Capital Management first reported a position in Privia Health in Q2 2021 and held it in 2 quarters.
  • CAAS Capital Management's Privia Health position peaked at $5.55M in Q2 2021.
  • 191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on CAAS Capital Management's 13F filing for Q1 2023, filed 15 May 2023.